// App-Quantinova.ai

3189 : Neuronal transcription factor BRN2 is an androgen suppressed driver of neuroendocrine differentiation in prostate cancer

Researchers

Presenter

  • Jennifer L. Bishop

Principal Investigators

  • Daksh Thaper

  • Sepideh Vahid

  • Ravi S. Munuganti

  • Paul Ahn

  • Alastair Davies

  • Kirsi Ketola

  • Ka Mun Nip

  • Dong Lin

  • Yuzhuo Wang

  • Himisha Beltran

  • Amina Zoubeidi

Medical Centers

  • Vancouver Prostate Ctr., Vancouver, British Columbia, Canada

  • Weill Cornell Medical College, New York, NY

Locations

  • United States

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Enzalutamide

  • Androgen Tear

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A